Búsqueda | BVS Medicinas Tradicionales, Complementarias, e Integrativas en las Américas

1.

[Bevacizumab/irinotecan. An active treatment for recurrent high grade gliomas: preliminary results of an ANOCEF Multicenter Study]. / Bevacizumab/irinotecan. Un nouveau traitement actif dans les gliomes de haut grade récidivants: résultats préliminaires d'une étude multicentrique de l'Anocef.

Guiu, S; Taillibert, S; Chinot, O; Taillandier, L; Honnorat, J; Dietrich, P Y; Maire, J-P; Guillamo, J S; Guiu, B; Catry-Thomas, I; Capelle, F; Thiebaut, A; Cartalat-Carel, S; Deville, C; Fumoleau, P; Desjardins, A; Xuan, K Hoang; Chauffert, B.

Rev Neurol (Paris) ; 164(6-7): 588-94, 2008.

Artículo en Francés | MEDLINE | ID: mdl-18565358

2.

Evaluation of oral versus intravenous dose of vinorelbine to achieve equivalent blood exposures in patients with solid tumours.

Bourgeois, H; Vermorken, J; Dark, G; Jones, A; Fumoleau, P; Stupp, R; Tourani, J; Brain, E; Nguyen, L; Lefresne, F; Puozzo, C.

Cancer Chemother Pharmacol ; 60(3): 407-13, 2007 Aug.

Artículo en Inglés | MEDLINE | ID: mdl-17541591

3.

Gemcitabine plus docetaxel: a new treatment option for anthracycline pretreated metastatic breast cancer patients?

Levy, C; Fumoleau, P.

Cancer Treat Rev ; 31 Suppl 4: S17-22, 2005.

Artículo en Inglés | MEDLINE | ID: mdl-16360543

4.

Population pharmacokinetics of short intravenous vinorelbine infusions in patients with metastatic breast cancer.

Deporte-Fety, R; Simon, N; Fumoleau, P; Campone, M; Kerbrat, P; Bonneterre, J; Fargeot, P; Urien, S.

Cancer Chemother Pharmacol ; 53(3): 233-8, 2004 Mar.

Artículo en Inglés | MEDLINE | ID: mdl-14634791

5.

Docetaxel is a major cytotoxic drug for the treatment of advanced breast cancer: a phase II trial of the Clinical Screening Cooperative Group of the European Organization for Research and Treatment of Cancer.

Chevallier, B; Fumoleau, P; Kerbrat, P; Dieras, V; Roche, H; Krakowski, I; Azli, N; Bayssas, M; Lentz, M A; Van Glabbeke, M.

J Clin Oncol ; 13(2): 314-22, 1995 Feb.

Artículo en Inglés | MEDLINE | ID: mdl-7844592

6.

Multicenter, randomized comparative study of two doses of paclitaxel in patients with metastatic breast cancer.

Nabholtz, J M; Gelmon, K; Bontenbal, M; Spielmann, M; Catimel, G; Conte, P; Klaassen, U; Namer, M; Bonneterre, J; Fumoleau, P; Winograd, B.

J Clin Oncol ; 14(6): 1858-67, 1996 Jun.

Artículo en Inglés | MEDLINE | ID: mdl-8656254

7.

Adjuvant treatment of node-positive breast cancer with cyclophosphamide, doxorubicin, fluorouracil, and vincristine versus cyclophosphamide, methotrexate, and fluorouracil: final report after a 16-year median follow-up duration.

Misset, J L; di Palma, M; Delgado, M; Plagne, R; Chollet, P; Fumoleau, P; Le Mevel, B; Belpomme, D; Guerrin, J; Fargeot, P; Metz, R; Ithzaki, M; Hill, C; Mathé, G.

J Clin Oncol ; 14(4): 1136-45, 1996 Apr.

Artículo en Inglés | MEDLINE | ID: mdl-8648368

8.

Results of a European Organization for Research and Treatment of Cancer/Early Clinical Studies Group phase II trial of first-line irinotecan in patients with advanced or recurrent squamous cell carcinoma of the cervix.

Lhommé, C; Fumoleau, P; Fargeot, P; Krakowski, Y; Dieras, V; Chauvergne, J; Vennin, P; Rebattu, P; Roche, H; Misset, J L; Lentz, M A; Van Glabbeke, M; Matthieu-Boué, A; Mignard, D; Chevallier, B.

J Clin Oncol ; 17(10): 3136-42, 1999 Oct.

Artículo en Inglés | MEDLINE | ID: mdl-10506610

9.

Population pharmacokinetics/pharmacodynamics of docetaxel in phase II studies in patients with cancer.

Bruno, R; Hille, D; Riva, A; Vivier, N; ten Bokkel Huinnink, W W; van Oosterom, A T; Kaye, S B; Verweij, J; Fossella, F V; Valero, V; Rigas, J R; Seidman, A D; Chevallier, B; Fumoleau, P; Burris, H A; Ravdin, P M; Sheiner, L B.

J Clin Oncol ; 16(1): 187-96, 1998 Jan.

Artículo en Inglés | MEDLINE | ID: mdl-9440742

10.

Phase I and pharmacokinetic study of IV vinflunine in cancer patients with liver dysfunction.

Delord, J P; Ravaud, A; Bennouna, J; Fumoleau, P; Favrel, S; Pinel, M C; Ferré, P; Saliba, F.

Invest New Drugs ; 31(3): 724-33, 2013 Jun.

Artículo en Inglés | MEDLINE | ID: mdl-22996801

11.

Modelling of ftorafur and 5-fluorouracil pharmacokinetics following oral UFT administration. A population study in 30 patients with advanced breast cancer.

Urien, S; Fumoleau, P; Campone, M; Kerbrat, P; Bonneterre, J; Fargeot, P; Deporte-Fety, R.

Cancer Chemother Pharmacol ; 52(2): 99-107, 2003 Aug.

Artículo en Inglés | MEDLINE | ID: mdl-12768319

12.

Premenopausal patients with node-positive resectable breast cancer. Preliminary results of a randomised trial comparing 3 adjuvant regimens: FEC 50 x 6 cycles vs FEC 50 x 3 cycles vs FEC 75 x 3 cycles. The French Adjuvant Study Group.

Fumoleau, P; Devaux, Y; Vo Van, M L; Kerbrat, P; Fargeot, P; Schraub, S; Mihura, J; Namer, M; Mercier, M.

Drugs ; 45 Suppl 2: 38-45, 1993.

Artículo en Inglés | MEDLINE | ID: mdl-7693420

13.

Phase II study of a new vinca alkaloid derivative, S12363, in advanced breast cancer.

Adenis, A; Pion, J M; Fumoleau, P; Pouillart, P; Marty, M; Giroux, B; Bonneterre, J.

Cancer Chemother Pharmacol ; 35(6): 527-8, 1995.

Artículo en Inglés | MEDLINE | ID: mdl-7882462

14.

UFT/leucovorin plus vinorelbine combination for advanced breast cancer.

Fumoleau, P; Déporte, R; Kerbrat, P; Bonneterre, J; Fargeot, P.

Oncology (Williston Park) ; 14(10 Suppl 9): 50-5, 2000 Oct.

Artículo en Inglés | MEDLINE | ID: mdl-11098494

15.

UFT plus oral calcium folinate/vinorelbine for advanced breast cancer.

Fumoleau, P; Déporte-Fety, R; Kerbrat, P; Laguerre, B.

Oncology (Williston Park) ; 13(7 Suppl 3): 86-90, 1999 Jul.

Artículo en Inglés | MEDLINE | ID: mdl-10442371

16.

[Paclitaxel (Taxol) and docetaxel (Taxotere): results of phase II trials in monochemotherapy]. / Paclitaxel (Taxol) et docetaxel (Taxotère): résultats des essais de phase II en monochimiothérapie.

Fumoleau, P; Perrocheau, G; Maugard-Louboutin, C; Lemevel, B.

Bull Cancer ; 82(8): 629-36, 1995 Aug.

Artículo en Francés | MEDLINE | ID: mdl-7492819

17.

High rate of extra-haematological toxicity compromises dose-dense sequential adjuvant chemotherapy for breast cancer.

Brain, E; Levy, C; Serin, D; Roché, H; Spielmann, M; Delva, R; Veyret, C; Mauriac, L; Rios, M; Martin, A L; Jimenez, M; Asselain, B; Gauthier, M; Bonnetain, F; Fumoleau, P.

Br J Cancer ; 105(10): 1480-6, 2011 Nov 08.

Artículo en Inglés | MEDLINE | ID: mdl-22009030

18.

Cost-effectiveness of adjuvant docetaxel for node-positive breast cancer patients: results of the PACS 01 economic study.

Marino, P; Siani, C; Roché, H; Protière, C; Fumoleau, P; Spielmann, M; Martin, A-L; Viens, P; Le Corroller Soriano, A-G.

Ann Oncol ; 21(7): 1448-1454, 2010 Jul.

Artículo en Inglés | MEDLINE | ID: mdl-20038515

19.

Epirubicin-vinorelbine vs FEC100 for node-positive, early breast cancer: French Adjuvant Study Group 09 trial.

Kerbrat, P; Roché, H; Bonneterre, J; Veyret, C; Lortholary, A; Monnier, A; Fumoleau, P; Fargeot, P; Namer, M; Chollet, P; Goudier, M-J; Audhuy, B; Simon, H; Montcuquet, P; Eymard, J-C; Walter, S; Clavère, P; Guastalla, J-P.

Br J Cancer ; 96(11): 1633-8, 2007 Jun 04.

Artículo en Inglés | MEDLINE | ID: mdl-17505516

20.

Long-term cardiac toxicity after adjuvant epirubicin-based chemotherapy in early breast cancer: French Adjuvant Study Group results.

Fumoleau, P; Roché, H; Kerbrat, P; Bonneterre, J; Romestaing, P; Fargeot, P; Namer, M; Monnier, A; Montcuquet, P; Goudier, M-J; Luporsi, E.

Ann Oncol ; 17(1): 85-92, 2006 Jan.

Artículo en Inglés | MEDLINE | ID: mdl-16251204

BVS Medicinas Tradicionales, Complementarias, e Integrativas en las Américas - MTCI

Configurar filtros

Su selección (0)

Formato de exportación:

Exportar: